Plasma drug concentration peaks within one hour after Reglanat Tablets are taken, followed by a rapid decline in blood concentration, and is cleared within four to six hours, so the half-life of Reglanat is about one hour. Repaglinide tablets are used for adults with type 2 diabetes who do not have a good effect of dietary control, weight loss or exercise, when metformin alone is not effective in controlling blood sugar, Repaglinide tablets can be used in combination with it. Possible adverse reactions to Reglanat Tablets include hypoglycemia, visual abnormalities, cardiovascular disease, abdominal pain and diarrhea, vomiting, hepatic dysfunction, and elevated liver enzyme markers. It is contraindicated in patients who are allergic to any of the ingredients in Repaglinide Tablets, in patients with type 1 diabetes mellitus, in patients with C-peptide-negative diabetes mellitus, in patients with diabetic ketoacidosis with or without coma, in patients with severe hepatic abnormalities, and it is not suitable to be used together with Gemfibrozil. If you need to use this product, please consult a professional doctor, follow the doctor’s instructions, reasonable use of medication.